JPRN-UMIN000010631已完成2 期
The efficacy of Zonisamide for BPSD in Dementia with Lewy bodies. A randomized, single-blind, placebo-control trial. - The efficacy of Zonisamide for BPSD in Dementia with Lewy bodies.
ational Center for Geriatrics and Gerontology0 个研究点目标入组 24 人开始时间: 2013年5月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 55years-old 至 84years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1 Patient with non DLB. 2 No focal lesion exists in brain MRI. 3 Has current serious illness, psychiatric problem or drug abuse. 4 Those who have used Zonisamide over before. 5 Those who have joined any clinical trial within 3 month. 6 Those who have received medications that affected the central nervous system within 4 weeks. 7 Dose of chronic medications that affect CNS should be stable for at least 4 weeks before Visit0. 8 Those who are judged inadequate by their doctor.
研究者
相似试验
尚未招募
3 期
The efficacy of Zonisamide for BPSD in Dementia with Lewy bodiesDementia with Lewy bodiesJPRN-UMIN000027312ational Center for Geriatrics and Gerontology90
已完成
3 期
DLB-ZDementia with Lewy bodiesJPRN-jRCTs041180125Washimi Yukihiko25
尚未招募
1 期
Zonisamide a new drug drug for parkinson disease as additional drug to ongoing treatment for Parkinson: a randomized double blind placebo control studyCTRI/2019/11/022095Atul Goel
已完成
4 期
A Clinical Trial to evaluate the safety and efficacy of zonisamide an antiepileptic drug in treatment patients with seizures (Fits). This is a postmarketing study to further confirm the safety and efficacy in large number of patients in the approved types of seizures.CTRI/2010/091/002925Eisai Pharmaceuticals India Private Limited.1st Floor, B-Wing, Marwah Centre, Krishanlal Marwah Marg, Andheri East, Mumbai - 400072655
已完成
不适用
Role of Zonisamide in Advanced Parkinson's Disease (PD) in Egyptian Population: Pilot StudyParkinson DiseaseNCT04182399Ain Shams University69